SC
IBB icon

Syon Capital’s iShares Biotechnology ETF IBB Stock Holding History

Syon Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$242K Buy
1,431
+228
+19% +$39K 0.01% 817
2025
Q4 		$203K Buy
+1,203
New +$195K 0.01% 867
2025
Q2 		– Sell
-4,119
Closed -$527K – 752
2025
Q1 		$527K Sell
4,119
-3,623
-47% -$491K 0.04% 299
2024
Q4 		$1.02M Buy
+7,742
New +$1.09M 0.09% 157

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Syon Capital's IBB Position: Q1 2026 in Review

Syon Capital increased its iShares Biotechnology ETF (IBB) stake by 19% in Q1 2026, buying an estimated $39K and bringing the position to 1,431 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #817.

Syon Capital first reported a position in IBB in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.02M in Q4 2024. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Syon Capital held 1,431 shares of iShares Biotechnology ETF worth $242K as of Q1 2026.
  • Syon Capital bought 228 iShares Biotechnology ETF shares in Q1 2026, an estimated $39K.
  • iShares Biotechnology ETF made up 0.01% of Syon Capital's portfolio in Q1 2026, its #817 holding.
  • Syon Capital first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 4 quarters since.
  • Syon Capital's iShares Biotechnology ETF position peaked at $1.02M in Q4 2024.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.